Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: John R Resseger who wrote (1110)	1/12/1999 4:19:00 PM
From: Amigo Mike	Respond to of 1476

Hi John, Try bigcharts.com Amigo Mike

To: John R Resseger who wrote (1110)	1/14/1999 11:09:00 PM
From: Amigo Mike	Read Replies (2) \| Respond to of 1476

Small news item ...... New Patent info: 5858352 ISSUE DATE: Jan-12-1999 Vaccine containing a Shigella bacterium having an enhanced antigenic property ASSIGNEE: Antex Biologics Inc. Gaithersburg, MD INVENTOR: Pace; John Lee Germantown, MD Walker; Richard Ives Gaithersburg, MD Frey; Steven Michael Germantown, MD OTHER DETAILS: Legal Rep: Pennie Edmonds LLP Application Date: May-30-1997 Application Number: 866586 Primary Examiner: Naff; David M. ABSTRACT: Methods using in vitro processes are disclosed for inducing or enhancing expression of enteric bacterial antigens or virulence factors. The methods, therefore, produce antigenically enhanced bacteria for use in vaccines. Also disclosed are methods for using the antigenically enhanced bacteria as well as the vaccines containing the enteric bacteria. Specifically, a whole enteric bacteria or components thereof, are provided by Shigella species. In addition to this microorganism there are other enteric bacteria, such as Campylobacter species and Helicobacter pylori, which are useful for inducing or enhancing expression of enteric bacterial antigens and/or virulence factors. Amigo Mike